DWDeutsche Welle·18hBusiness
score-0.60
BioNTech Bets on Ambitious Cancer Trials to Evolve From COVID Vaccine Maker Into Biotech Giant
Original
BioNTech: From COVID vaccine pioneer to uncertain future
“Emphasizes decline, uncertainty, and existential risk ('one-hit wonder') while acknowledging potential recovery through cancer trials.”